How readily does ketorolac penetrate cerebrospinal fluid in children?

Journal of Clinical Pharmacology

Volumn 48, Issue 4, 2008, Pages 495-501

  Kumpulainen, Elina ^a,b   Kokki, Hannu ^a,b,d   Laisalmi, Merja ^b   Heikkinen, Marja ^b   Savolainen, Jouko ^c   Rautio, Jarkko ^a   Lehtonen, Marko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Oy Fennopharma Ltd   (Finland)

^d Department of Anesthesiology and Intensive Care ^*  (Finland)

Author keywords

Cerebrospinal fluid; Child; Infant; Ketorolac; Pharmacokinetics

Indexed keywords

KETOROLAC;

ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG PENETRATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INFANT; MALE; MASS SPECTROMETRY; PEDIATRIC SURGERY; SPINAL ANESTHESIA;

ADOLESCENT; ANESTHESIA, SPINAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD-BRAIN BARRIER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; KETOROLAC; MALE; PROSPECTIVE STUDIES; SAMPLE SIZE; SURGICAL PROCEDURES, OPERATIVE;

EID: 40749086824     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007313389     Document Type: Article

References (21)

1. Maunuksela EL, Kokki H., Bullingham RE Comparison of intravenous ketorolac with morphine for postoperative pain in children. Clin Pharmacol Ther. 1992 ; 52: 436-443.
2. Rice AS, Whitehead EM, O'Sullivan G., Lloyd J., Bullingham RE Speed of onset of analgesic effect of intravenous ketorolac compared to morphine and placebo. Eur J Anaesthesiol. 1995 ; 12: 313-317.
3. Forrest JB, Heitlinger EL, Revell S. Ketorolac for postoperative pain management in children. Drug Saf. 1997 ; 16: 309-329. Review.
4. Warner TD, Giulaino F., Vojnovic I., Bukasa A., Mitchell JA, Vane JR Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999 ; 96: 7563-7568.
5. Summary of product characteristics (SPC) Toradol. Lääkelaitos Läkemedelsverket National Agency for Medicines Web site. http://spc.nam.fi/indox/nam/html/nam/humspc/2/196332.shtml. Accessed May 10, 2007.
6. Svensson CI, Yaksh TL The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol. 2002 ; 42: 553-583.
7. Malmberg AB, Yaksh TL Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992 ; 263: 136-146.
8. Eisenach JC, Curry R., Hood DD, Yaksh TL Phase I safety assessment of intrathecal ketorolac. Pain. 2002 ; 99: 599-604.
9. Mannila A., Kokki H., Heikkinen M., et al. Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children. Clin Pharmacokinet. 2006 ; 45: 737-743.
10. Mannila A., Kumpulainen E., Lehtonen M., et al. Plasma and cerebrospinal fluid concentrations of indomethacin in children after intravenous administration. J Clin Pharmacol. 2007 ; 47: 94-100.
11. Kokki H., Kumpulainen E., Lehtonen M., Laisalmi M., Heikkinen M., Savolainen J. Cerebrospinal fluid distribution of ibuprofen after intravenous administration in children. Pediatrics. 2007 ; 120 (4). e1002 - e1008. doi:10.1542/peds.2007-0064.
12. Kumpulainen E., Kokki H., Halonen T., Heikkinen M., Savolainen J., Laisalmi M. Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration. Pediatrics. 2007 ; 119: 766-771.
13. Rice AS, Lloyd J., Bullingham RE, O'Sullivan G. Ketorolac penetration into the cerebrospinal fluid of humans. J Clin Anesth. 1993 ; 5: 459-462.
14. Dsida RM, Wheeler M., Birmingham PK, et al. Age-stratified pharmacokinetics of ketorolac tromethamine in pediatric surgical patients. Anesth Analg. 2002 ; 94: 266-270.
15. Hamunen K., Maunuksela EL, Sarvela J., Bullingham RE, Olkkola KT Stereoselective pharmacokinetics of ketorolac in children, adolescents, and adults. Acta Anaesthesiol Scand. 1999 ; 43: 1041-1046.
16. Zhu X., Conklin DR, Eisenach JC Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain. 2003 ; 104: 15-23.
17. Reinold H., Ahmadi S., Depner UB, et al. Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest. 2005 ; 115: 673-679.
18. Khamdang S., Takeda M., Noshiro R., et al. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 2002 ; 303: 534-539.
19. Reid G., Wielinga P., Zelcer N., et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal anti-inflammatory drugs. Proc Natl Acad Sci U S A. 2003 ; 100: 9244-92449.
20. Martin T., Buechler N., Eisenach J. Intrathecal administration of a cyclooxygenase-1, but not a cyclooxygenase-2 inhibitor, reverser the effects of laparotomy on exploratory activity in rats. Anesth Analg. 2006 ; 103: 690-695.
21. Yaksh TL, Horais KA, Tozier N., et al. Intrathecal ketorolac in dogs and rats. Toxicol Sci. 2004 ; 80: 322-334.